SG11202110344YA - Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds - Google Patents

Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds

Info

Publication number
SG11202110344YA
SG11202110344YA SG11202110344YA SG11202110344YA SG11202110344YA SG 11202110344Y A SG11202110344Y A SG 11202110344YA SG 11202110344Y A SG11202110344Y A SG 11202110344YA SG 11202110344Y A SG11202110344Y A SG 11202110344YA SG 11202110344Y A SG11202110344Y A SG 11202110344YA
Authority
SG
Singapore
Prior art keywords
phosphoramidates
triphosphate
nucleotides
salt
anticancer compounds
Prior art date
Application number
SG11202110344YA
Other languages
English (en)
Inventor
Hugh Griffith
Michaela Serpi
Fabrizio Pertusati
Magdalena Slusarczyk
Ciano Samuele Di
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NuCana plc filed Critical NuCana plc
Publication of SG11202110344YA publication Critical patent/SG11202110344YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SG11202110344YA 2019-04-01 2020-04-01 Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds SG11202110344YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1904544.2A GB201904544D0 (en) 2019-04-01 2019-04-01 Anticancer compounds
PCT/GB2020/050871 WO2020201751A1 (en) 2019-04-01 2020-04-01 Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds

Publications (1)

Publication Number Publication Date
SG11202110344YA true SG11202110344YA (en) 2021-10-28

Family

ID=66443062

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110344YA SG11202110344YA (en) 2019-04-01 2020-04-01 Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds

Country Status (16)

Country Link
US (1) US20220024963A1 (ja)
EP (1) EP3947408B1 (ja)
JP (1) JP2022528679A (ja)
KR (1) KR20210146960A (ja)
CN (1) CN113661169A (ja)
AU (1) AU2020251748A1 (ja)
BR (1) BR112021019282A2 (ja)
CA (1) CA3133894A1 (ja)
CL (1) CL2021002536A1 (ja)
EA (1) EA202192660A1 (ja)
GB (1) GB201904544D0 (ja)
IL (1) IL286815A (ja)
MA (1) MA55512A (ja)
MX (1) MX2021012038A (ja)
SG (1) SG11202110344YA (ja)
WO (1) WO2020201751A1 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317009D0 (en) 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
GB0505781D0 (en) 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
DK3031812T3 (en) 2011-03-01 2018-09-17 NuCana plc CHEMICAL COMPOUNDS
IL291927A (en) 2014-11-28 2022-06-01 NuCana plc Oligonucleotides containing modified nucleosides
JP6735751B2 (ja) * 2014-12-15 2020-08-05 エモリー ユニバーシティー Ｂ型肝炎ウイルスの治療のためのホスホルアミデート

Also Published As

Publication number Publication date
IL286815A (en) 2021-10-31
US20220024963A1 (en) 2022-01-27
CN113661169A (zh) 2021-11-16
KR20210146960A (ko) 2021-12-06
AU2020251748A1 (en) 2021-10-14
EP3947408B1 (en) 2023-06-07
EP3947408A1 (en) 2022-02-09
WO2020201751A1 (en) 2020-10-08
CA3133894A1 (en) 2020-10-08
JP2022528679A (ja) 2022-06-15
EA202192660A1 (ru) 2022-01-14
GB201904544D0 (en) 2019-05-15
BR112021019282A2 (pt) 2022-02-01
MX2021012038A (es) 2021-11-03
CL2021002536A1 (es) 2022-06-17
MA55512A (fr) 2022-02-09

Similar Documents

Publication Publication Date Title
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
EA201792519A1 (ru) Противогрибковые соединения
PH12017500276A1 (en) Aminopyrimidinyl compounds as jak inhibitors
IL263121B (en) History of nucleoside phosphoramidate as anticancer agents
MD20170046A2 (ro) Metode pentru tratamentul infecţiilor virale cu Filoviridae
EA201491493A1 (ru) Замещенные нуклеозиды, нуклеотиды и их аналоги
ZA201801465B (en) 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers
EA201892769A3 (ru) Сложные диэфиры ациклических нуклеозидфосфонатов
HK1255108A1 (zh) 核苷類藥物的氨基磷酸酯衍生物的製劑
HUE052335T2 (hu) Pirrolok, diazolok, triazolok vagy tetrazolok ízeltlábúak irtására
MX2018007782A (es) Forma cristalina de gemcitabina.
MY178745A (en) Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them
IL288116A (en) A process for the preparation of galnac phosphoramidite epimers
IL286815A (en) Nucleotide triphosphate salt phosphoramidates as anticancer compounds
IL274808A (en) Phosphoramidate diphosphate salts of nucleosides as anticancer compounds
IN2014MU00071A (ja)